A Life-Changing Class of its Own
Utilizing the novel structural and functional properties of theta-defensins as a template to design OrynotidesTM , new therapeutic drug candidates to treat complex, difficult-to-treat diseases.
Utilizing the novel structural and functional properties of theta-defensins as a template to design OrynotidesTM , new therapeutic drug candidates to treat complex, difficult-to-treat diseases.
Utilizing the novel structural and functional properties of theta-defensins as a template to design OrynotidesTM, new therapeutic drug candidates to treat complex, difficult-to-treat diseases
Orynotides are a novel, patented class of therapeutics bioinspired by naturally occurring peptides discovered in non-human primates. Orynotides are safe and stable, exhibit low toxicity and low immunogenicity, and are easy to produce. Therapeutic applications include diseases for which current treatments have black box warnings and limited efficacy. Thus, Orynotides offer a new and revolutionary therapeutic approach for treatment of chronic and life-threatening diseases.
Our goal is to become the leader in new therapeutic development to safely treat autoimmune and inflammatory diseases, infectious diseases, as well as combination immunotherapy for cancer treatment.